News & Analysis on Clinical Trial Services & Contract Research And Development
Fujitsu Laboratories has reported a successful experiment using its BioServer, designed to overcome one of the primary obstacles to drug discovery - taking the huge amount of data coming from genomics efforts and applying it to the design of new drugs.
Chiron has had to cease production at a UK plant making influenza vaccines, exacerbating an existing shortage of the jab ahead of this year's flu season.
The biotech industry managed to raise almost $6 billion during the third quarter bringing the total raised this year to $20 billion (€16.2 billion), an increase of $3.2 billion from this time last year, reflecting the growing confidence in the biotech...
Scientists have reworked the mechanism of how enzymes work, forcing the pharmaceutical industry to rethink its views on the design of biological catalysts and new drugs.
BASF has threatened to relocate research into 'green genetic engineering' to other countries if German law continues to restrict R&D into plant biotechnology, with applications as diverse as crop biomanufacturing of proteins and GM foods.
Becton Dickinson is planning to sell of its Clontech molecular biology business, five years after purchasing it for $200 million.
Franz Humer, president of the European Federation of Pharmaceutical Industries and Associations and chief executive of Roche, has issued a plea for a concerted effort at improving Europe's science base at the European Parliament.
From the 1st January 2005, industrial carbon dioxide (CO2) emissions will come under regulation through the introduction of the EU Emissions Trading Scheme (EU ETS).
Drug maker Samaritan Pharmaceuticals, has entered into a collaboration with Pharmaplaz to produce and supply Samiritan's lead compound and pipeline of drugs that includes treatments for AIDS, Alzheimer's, cancer and cardiovascular disease.
Cancer treatment to kill tumours could be made more effective by a revolutionary approach to angiogenesis which takes the unusual approach of opening up the tumour blood supply allowing better access for cancer drugs and more effective radiotherapy.
The US Food and Drug Administration will start using a risk-based approach for prioritising site inspections for certain pharmaceutical products, the agency has announced in a final report on its current good manufacturing practice (cGMP) initiative.
Integrated material handling solutions provider FKI Logistex has expanded its range of conveying surface options to make pallet loading more adaptable and cost-effective for suppliers.